Trial Profile
A Multi-center Study evaluating the Safety and Efficacy of Abatacept in Rheumatoid Arthritis Patients with Pulmonary Complications from the Tsurumai Biologics Communication Registry
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2015 New trial record